Company Info

Spera Pharma, Inc.

CDMO

Overview

SPERA PHARMA was established as a new company on July 1, 2017, through a strategic partnership between Bushu Pharmaceuticals and Takeda Pharmaceutical Company in the area of CMC business operations. Under their agreement, Bushu Pharmaceuticals took over Takeda’s facilities in the Juso area (Yodogawa-ku, Osaka City), taking responsibility for part of the Pharmaceutical Science Department (formerly the CMC Center) and its employees. As Takeda Pharmaceutical’s strategic partner, SPERA PHARMA will be engaged in developing drug substance processes, designing drug formulations, developing test methods, manufacturing investigational drugs, and conducting related business operations.

Contributors

Toshio Yoshioka